ERA-NET EuroNanoMed: an efficient tool to foster the competitiveness of European nanomedicine actors through the support of transnational collaborative and multidisciplinary research projects.
The ERA-NET scheme, created by the European Commission (EC), serves as a powerful instrument for gathering the main funding organisations from Member States, Associated Countries, regions and other countries for pooling resources and fund transnational research projects on Nanomedicine. Pure nationally funded programmes often face difficulties to successfully translate fundamental research in first clinical stages, as in many member states there are too few players in the specific domain of nanomedicine. Therefore, the main goal of EuroNanoMed (ENM) partners is to foster the competitiveness of European nanomedicine actors through the support of transnational collaborative and multidisciplinary research projects and establishing collaborations with key initiatives in the field. EuroNanoMed has proven to be a solid, competent and internationally recognized consortium, which has established strong collaborations with other actors in the European landscape, including ETPN
EuroNanoMed III was built on the foundations of two other ERA-NETs. During the period 2009-2015, the ERANETs ENM I & II (2009-2011 and 2012-2016) successfully launched 7 joint calls for proposals (the 7th is currently open) in line with the strategic priorities of the European Technology Platform on Nanomedicine (ETPN), which allowed ENM to fund 51 transnational research projects involving 269 partners from 25 ountries/regions participating in the calls, with about € 45,5 million funding from the ENM funding agencies (see section 1.3 for details).
